Natasha Hernday
Board Member
Janux Therapeutics, Inc. (JANX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Natasha Hernday
Natasha Hernday is recorded as Board Member at Janux Therapeutics, Inc. (JANX). Janux Therapeutics, Inc. reported in an 8-K filed July 22, 2024 that Natasha Hernday was appointed Class II director of the Company, effective July 19, 2024.
“On July 19, 2024, the Board, upon the recommendation of the Nominating and Governance Committee, appointed (i) Natasha Hernday as a Class II director of the Company, with a term of office expiring at the Company's 2026 annual meeting of stockholders, or until her earlier death, resignation or removal”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Janux Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David Campbell CEO, Board Member
- Ron Barrett, Ph.D. Chairman
- Tighe Reardon CFO
- Alana McNulty Board Member
- Eric Dobmeier Board Member
- Ronald Barrett, Ph.D. Board Member
- Winston Kung Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.